| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 686425 | Null | 0.0186200143729973 | 0.010998068 |
| NSC 694456 | Null | 0.0186200143729973 | -0.14932749 |
| NSC 702106 | Null | 0.0186200143729973 | 0.23978019 |
| NSC 703138 | Null | 0.0186200143729975 | -0.13301918 |
| NSC 762542 | Null | 0.0186200143729975 | -0.07913994 |
| NSC 107392 | 5-HP | 0.0219024304994663 | 0.13241467 |
| NSC 130279 | 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) | 0.0219024304994663 | 0.0686781 |
| NSC 13275 | Null | 0.0219024304994663 | -0.062632346 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0219024304994663 | -0.011843507 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0219024304994663 | 0.02649862 |